WE TURN

Life Sci Turns 5

THIS YEAR 

BLOG

Celularity: Productizing Placental-Derived Stem Cells for Any Patient

Celularity is a clinical-stage biotechnology company focusing on the next evolution in cellular medicine by developing off-the-shelf placenta-derived allogeneic cell therapies, including genetically modified natural killer (NK) cells and T cells engineered with a chimeric antigen receptor (CAR-T cells) that target indications across cancer as well as infectious and degenerative diseases . . .